Point72 Asset Management’s Provention Bio PRVB Stock Holding History
Bought
Maintained
Sold
Other funds holding PRVB
Point72 Asset Management's PRVB Position: Q2 2023 in Review
Point72 Asset Management sold out of Provention Bio (PRVB) in Q2 2023, closing a stake of 2,377 shares — an estimated $57.3K sold.
Point72 Asset Management first reported a position in PRVB in Q4 2018 and held it in 3 quarters. The position peaked at $131K in Q1 2019. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.
- Point72 Asset Management reported no remaining Provention Bio position as of Q2 2023 after selling out during the quarter.
- Point72 Asset Management sold 2,377 Provention Bio shares in Q2 2023, an estimated $57.3K.
- Point72 Asset Management first reported a position in Provention Bio in Q4 2018 and held it in 3 quarters.
- Point72 Asset Management's Provention Bio position peaked at $131K in Q1 2019.
- 1 fund tracked by Wall St. Rank held Provention Bio as of Q2 2023.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.